
28/07/2025
IEB PHARMA 🌍 | Global Oncology Access
Now available: Osimert 80 mg (Osimertinib) – 30 Tablets
Manufactured by: Everest Pharmaceutical Ltd
Osimert 80 mg is a third-generation EGFR-TKI, provided under regulated access for oncology use. This product is intended strictly for use under the supervision of a licensed medical practitioner and is dispensed only against a valid prescription.
🔸 For professional use only
🔸 Available for worldwide dispatch as per regulatory compliance
🔸 Strictly not for direct promotional sale
📌 Kindly consult with your healthcare provider for appropriate guidance.
📦 To inquire about availability, authorized medical professionals may contact us through official channels.